ArticleACS omega2023
Preparation of Spherical HMX/DMF Solvates, Spherical HMX Particles, and HMX@NTO Composites: A Way to Reduce the Sensitivity of HMX.
Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 25 citations in OpenAlex.
- Spray flash evaporation, a promising path to fundamental research and industrial processes: elaboration of a micronized mixed HMX/LLM-105 energetic material.RSC advances · 2026Article
- Article
- Molecular dynamics simulations for the sensitivity and moisture adsorption on the surface of a novel cocrystal: CL-20/DNAN.Journal of molecular modeling · 2025Article
- Facilitating polymorphic crystallization of HMX through ultrasound and trace additive assistance.Ultrasonics sonochemistry · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To reduce the sensitivity of HMX (HMX = high-melting explosive-cyclotetramethylenetetranitramine), spherical HMX/DMF (DMF = dimethylformamide) solvates, spherical HMX particles, and HMX@NTO (NTO = 1,2,4-triazol-5-one) composites are prepared by crystallization. The structure and performance of spherical HMX crystals, HMX particles, and HMX@NTO composites are characterized by X-ray diffraction, Fourier-transform infrared spectroscopy, scanning electron microscopy, differential scanning calorimetry, accelerating rate calorimetry, and mechanical sensitivity test. The results show that the space group of the spherical HMX/DMF solvate is
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.